journal article·2017-10-18

Multifunctional Gene Carriers with Enhanced Specific Penetration and Nucleus Accumulation to Promote Neovascularization of HUVECs in Vivo

Xuefang Hao, Qian Li, Jintang Guo, Xiangkui Ren, Yakai Feng, Changcan Shi, Wencheng Zhang

Publisher page

Abstract

Recently, gene therapy has attracted much attention, especially for the treatment of vascular disease. However, it is still challenging to develop the gene carriers with high biocompatibility as well as highly efficient gene delivery to overcome multiple barriers. Herein, a frequently used cell-penetrating peptide PKKKRKV (TAT) was selected as a functional sequence of the gene carrier with distinctive cell-penetrating ability. REDV peptide with selectively targeting function for endothelial cells (ECs) and nuclear localization signals (NLS) were integrated with this TAT peptide to obtain a highly efficient gene delivery system with ECs specificity and nucleus accumulation capacity. Besides, the glycine sequences with different repeat numbers were inserted into the above integrated peptide. These glycine sequences acted as a flexible spacer arm to exert the targeting, cell-penetrating, and nucleus accumulation functions of each functional peptide. Three tandem peptides REDV-G m -TAT-G m -NLS ( m = 0, 1, and 4) complexed with pZNF580 plasmid to form gene complexes. The results of hemocompatibility and cytocompatibility indicated that these peptides and gene complexes were nontoxic and biocompatible. The internalization efficiency and mechanism of these gene complexes were investigated. The internalization efficiency was improved as the introduction of targeting REDV and glycine sequence, and the REDV-G 4 -TAT-G 4 -NLS/pZNF580 (TP-G4/pZNF580) complexes showed the highest cellular uptake among the gene complexes. The TP-G4/pZNF580 complexes also presented significantly higher internalization efficiency (∼1.36 times) in human umbilical vein endothelial cells (HUVECs) than human umbilical artery smooth muscle cells. TP-G4/pZNF580 complexes substantially promoted the expression of pZNF580 by confocal live cell imaging, gene delivery efficiency, and HUVECs migration assay. The in vitro and in vivo revascularization ability of transfected HUVECs was further enhanced obviously. In conclusion, these multifunctional REDV-G m -TAT-G m -NLS peptides offer a promising and efficacious delivery option for neovascularization to treat vascular diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical Engineering and Technology, Tianjin University, Yaguan Road 135, Tianjin 300350, China

Collaborative Innovation Center of Chemical Science and Chemical Engineering, Tianjin 300350, China

Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin 300072, China

School of Ophthalmology & Optometry, Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang 325011, China

Wenzhou Institute of Biomaterials and Engineering, CNITECH, CAS, Wenzhou, Zhejiang 325011, China

Department of Physiology and Pathophysiology, Logistics University of Chinese People’s Armed Police Force, Tianjin 300309, China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Wenzhou Municipality

References (66)

Show source-provided references
1. 10.1002/adhm.20160134010.1002/adhm.201601340 ↗
2. 10.1039/C4CS00483C10.1039/C4CS00483C ↗
3. 10.1039/C6TB00024J10.1039/C6TB00024J ↗
4. 10.1016/j.biomaterials.2015.10.02010.1016/j.biomaterials.2015.10.020 ↗
5. 10.1002/adma.20150508810.1002/adma.201505088 ↗
6. 10.1002/advs.20160005810.1002/advs.201600058 ↗
7. 10.1089/ten.teb.2009.008510.1089/ten.teb.2009.0085 ↗
8. 10.1080/14712598.2017.128917010.1080/14712598.2017.1289170 ↗
9. 10.1016/j.addr.2016.11.00310.1016/j.addr.2016.11.003 ↗
10. 10.1021/acsami.6b0064910.1021/acsami.6b00649 ↗
11. 10.1002/advs.20160022810.1002/advs.201600228 ↗
12. 10.1007/s11705-017-1623-510.1007/s11705-017-1623-5 ↗
13. 10.1007/s11705-016-1582-210.1007/s11705-016-1582-2 ↗
14. 10.1016/j.biomaterials.2015.10.06210.1016/j.biomaterials.2015.10.062 ↗
15. 10.1002/adhm.20140081710.1002/adhm.201400817 ↗
16. 10.1016/j.biomaterials.2014.04.11010.1016/j.biomaterials.2014.04.110 ↗
17. 10.1039/c3tb21601b10.1039/c3tb21601b ↗
18. 10.1002/macp.20140034510.1002/macp.201400345 ↗
19. 10.1039/C5TB02310F10.1039/C5TB02310F ↗
20. 10.1039/C6TB00686H10.1039/C6TB00686H ↗
21. 10.1021/acsami.5b0239910.1021/acsami.5b02399 ↗
22. 10.1021/acsami.5b0628610.1021/acsami.5b06286 ↗
23. 10.1039/C4TB02019G10.1039/C4TB02019G ↗
24. 10.1021/acsami.6b1476910.1021/acsami.6b14769 ↗
25. 10.1039/C6TB02379G10.1039/C6TB02379G ↗
26. 10.1039/C6TB02212J10.1039/C6TB02212J ↗
27. 10.1016/j.tsf.2012.03.04110.1016/j.tsf.2012.03.041 ↗
28. 10.1016/j.colsurfb.2011.01.02810.1016/j.colsurfb.2011.01.028 ↗
29. 10.1002/marc.20160034510.1002/marc.201600345 ↗
30. 10.1002/adma.20140471510.1002/adma.201404715 ↗
31. 10.1016/j.addr.2016.06.00810.1016/j.addr.2016.06.008 ↗
32. 10.1016/j.jconrel.2016.02.00210.1016/j.jconrel.2016.02.002 ↗
33. 10.1007/s11705-017-1612-810.1007/s11705-017-1612-8 ↗
34. 10.1007/s11705-015-1538-y10.1007/s11705-015-1538-y ↗
35. 10.1021/ar200256e10.1021/ar200256e ↗
36. 10.1016/j.addr.2016.04.03110.1016/j.addr.2016.04.031 ↗
37. 10.1021/acs.nanolett.6b0002010.1021/acs.nanolett.6b00020 ↗
38. 10.1016/j.actbio.2015.11.02910.1016/j.actbio.2015.11.029 ↗
39. 10.1021/nn304707b10.1021/nn304707b ↗
40. 10.1021/acs.molpharmaceut.5b0042810.1021/acs.molpharmaceut.5b00428 ↗
41. 10.1016/j.biomaterials.2014.02.03110.1016/j.biomaterials.2014.02.031 ↗
42. 10.1016/j.jconrel.2017.02.02910.1016/j.jconrel.2017.02.029 ↗
43. 10.1039/c3tb00226h10.1039/c3tb00226h ↗
44. 10.1021/acs.molpharmaceut.6b0033810.1021/acs.molpharmaceut.6b00338 ↗
45. 10.1016/j.actbio.2016.11.00410.1016/j.actbio.2016.11.004 ↗
46. 10.1021/bc300677n10.1021/bc300677n ↗
47. 10.1039/C5NR06903C10.1039/C5NR06903C ↗
48. 10.1007/s11010-014-2061-z10.1007/s11010-014-2061-z ↗
49. 10.1039/C5BM00629E10.1039/C5BM00629E ↗
50. 10.1016/j.tibtech.2016.12.00910.1016/j.tibtech.2016.12.009 ↗
51. 10.1021/acs.langmuir.6b0368510.1021/acs.langmuir.6b03685 ↗
52. 10.1016/j.ijbiomac.2016.04.07210.1016/j.ijbiomac.2016.04.072 ↗
53. 10.1021/acsami.7b0038710.1021/acsami.7b00387 ↗
54. 10.1039/C6QM00046K10.1039/C6QM00046K ↗
55. 10.1039/C6BM00856A10.1039/C6BM00856A ↗
56. 10.1021/ar200256e10.1021/ar200256e ↗
57. 10.1021/bm501777a10.1021/bm501777a ↗
58. 10.1016/j.ijcard.2017.02.08010.1016/j.ijcard.2017.02.080 ↗
59. 10.1002/adma.20160662810.1002/adma.201606628 ↗
60. 10.1021/nn507269g10.1021/nn507269g ↗
61. 10.1016/j.biomaterials.2017.02.03610.1016/j.biomaterials.2017.02.036 ↗
62. 10.1021/acsami.5b1029510.1021/acsami.5b10295 ↗
63. 10.1021/nn301975s10.1021/nn301975s ↗
64. 10.1016/j.jconrel.2010.12.00910.1016/j.jconrel.2010.12.009 ↗
65. 10.1002/jbm.a.3407710.1002/jbm.a.34077 ↗
66. 10.1016/j.biomaterials.2012.12.03610.1016/j.biomaterials.2012.12.036 ↗